Kernal is creating mRNA 2.0 therapies that work in specific cells Status: Active. Batch: YC Summer 2020. HQ: Cambridge, MA, USA. Industry: Healthcare. https://www.kernalbio.com/
Details
city
Cambridge
cohort year
2020
country
United States
exited
false
has patents
true
industry
healthcare
one liner
Kernal is creating mRNA 2.0 therapies that work in specific cells